Short answer
Ardent Health, Inc. (ARDT) filed an 8-K current report with the SEC on June 30, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Former CEO Martin J. Bonick’s departure and Board resignation effective June 2, 2026.
Ardent Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Former CEO Martin J. Bonick’s departure and Board resignation effective June 2, 2026
- Separation agreement provides severance consistent with Company termination without “Cause”
- Equity awards governed by existing incentive plan and award agreements, affecting vesting and forfeiture
- Twelve-month non-competition and non-solicitation restrictions following departure
- Agreement effective June 2, 2026 and filed as Exhibit 10.1
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Ardent Health, Inc. 8-K filings
Get the next ARDT 8-K as it lands
Follow ARDT for push alerts, or ask the research agent what this filing means.